Company Filing History:
Years Active: 2024-2025
Title: Adam Neil Reid: Innovator in APOL1 Inhibition
Introduction
Adam Neil Reid is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of APOL1 inhibitors. With a total of 2 patents to his name, Reid is recognized for his innovative approaches to treating APOL1-mediated diseases.
Latest Patents
Reid's latest patents focus on APOL1 inhibitors and methods of use. These patents provide compounds of formula (II) and detail methods for preparing these compounds, including stereoisomers, tautomers, and pharmaceutically acceptable salts. Additionally, the patents outline methods for inhibiting APOL1 and treating related diseases, disorders, or conditions in individuals.
Career Highlights
Adam Neil Reid is currently associated with Maze Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in the quest for effective treatments for conditions linked to APOL1.
Collaborations
Reid collaborates with notable colleagues, including Patrick Sang Tae Lee and Todd Jonathan August Ewing. Their combined expertise enhances the innovative environment at Maze Therapeutics.
Conclusion
Adam Neil Reid stands out as a key figure in the field of biotechnology, particularly for his work on APOL1 inhibitors. His contributions are shaping the future of treatments for APOL1-mediated conditions.